APPENDIX C. Abbreviations Used in This Report

Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.

ACIP

Advisory Committee on Immunization Practices

intramuscularly

ACOG

American College of Obstetricians and Gynecologists

IOM

Institute of Medicine

acellular pertussis vaccine (without tetanus and diphtheria toxoids)

international units

B. bronchiseptica

Bordetella bronchiseptica

limit of flocculation unit

B. holmseii

Bordetella holmseii

MCV4

tetravalent meningococcal conjugate vaccine

B. parapertussis

Bordetella parapertussis

MDPH

Massachusetts Department of Public Health

B. pertussis

Bordetella pertussis

mIU

milli-international unit

C. diphtheriae

Corynebacterium diphtheriae

Milliliter

C. tetani

Clostridium tetani

MPHBL

Massachusetts Public Health Biologic Laboratory

C. ulcerans

Corynebacterium ulcerans

MPSV4

tetravalent meningococcal polysaccharide vaccine

confidence interval

NHANES

National Health and Nutritional Examination Survey

CSTE

Council of State and Territorial Epidemiologists

NNDSS

National Notifiable Diseases Surveillance System

DFA

direct fluorescent antibody

PCR

polymerase chain reaction

pediatric diphtheria and tetanus toxoids vaccine

2-PE

2-phenoxyethanol

DTaP

pediatric diphtheria and tetanus toxoids and acellular pertussis vaccine

PRN

Pertactin

DTP

pediatric diphtheria and tetanus toxoids and whole cell pertussis vaccine

PPD

tuberculin purified protein derivative

ELISA units

pertussis toxin

ELISA

enzyme-linked immunoabsorbant assay

QALY

quality adjusted life year

ELS

extensive limb swelling

SAE

serious adverse event

FDA

Food and Drug Administration

sanofi Pasteur

FHA

filamentous hemagglutinin

SPSS

Supplemental Pertussis Surveillance System

FIM

Fimbriae

Tdap

adult tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine

GBS

Guillain-Barré syndrome

adult tetanus and diphtheria toxoids vaccine

GMC

geometric mean antibody concentration

TIG

tetanus immune globulin

GMT

geometric mean titer

TIV

trivalent inactivated influenza vaccine

GSK

GlaxoSmithKline Biologicals

tetanus toxoid vaccine

HAI

hemagglutinin inhibition

VAERS

Vaccine Adverse Event Reporting System

HCP

health-care personnel

VICP

Vaccine Injury Compensation Program

HIV

human immunodeficiency virus

VRBPAC

Vaccines and Related Biological Products Advisory Committee

HICPAC

Healthcare Infection Control Practices Advisory Committee

µg

micrograms

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

mmwrq@cdc.gov

Date last reviewed: 12/8/2006